Skip to main content
  • English
    • Nederlands
    • Français

Home
  • Sign In
  • Therapeutic areas
    • Cardiology
      • Heart Failure
      • ASCVD
    • Dermatology
    • Hematology
      • ITP
    • Neurology
      • Multiple Sclerosis
    • Oncology
      • Breast Cancer
      • Prostate Cancer (mCRPC)
    • Ophthalmology
      • Retinal diseases
    • Respiratory
    • Rheumatology
  • Congresses & Events
    • Cardiology
      • BSC
      • ESC
    • Dermatology
      • EADV
      • Sharing is Caring
    • Hematology
      • ASH
      • EHA
      • ESH
    • Neurology
      • CMSC
      • EAN
      • ECTRIMS
    • Oncology
      • ASCO
      • ESMO
      • EBCC
      • SABCS
    • Rheumatology
      • Sharing is Caring
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

Page protected by password
Netelroos - Doe the test
Behandelingen Netelroos
Search
  • Reimbursement - Cosentyx PsO / HS

    Convenient prescription¹ Initial reimbursement request for Cosentyx ® : 8 packs of 1x 300 mg for first 16 weeks 5 for the start-up 3 for the maintenance treatment (monthly injections)

    Prolongation of reimbursement...

    Twitter Linkedin Facebook Pinterest Google plus
  • Cosentyx® HS Secukinumab 300 mg - Reimbursement form initiation (Dutch)

      Download Dutch document    
  • Cosentyx® HS Secukinumab 300 mg - Reimbursement form initiation (French)

      Download French document    
  • Cosentyx® PsO: Travel Kit (English)

        .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button below
  • Patient Resources - PsO / HS

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile - Kesimpta

    Twitter Linkedin Facebook Pinterest Google plus
  • Efficacy - Kesimpta

    Twitter Linkedin Facebook Pinterest Google plus
  • Efficacy

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety Profile

    As with every medicine, when using REVOLADE, side effects can occur. In the case of serious side effects, it is possible that a dose adjustment is necessary. See also the Summary of Product Characteristics for a full overview of the side effects and side...
    Twitter Linkedin Facebook Pinterest Google plus
  • Cosentyx® HS Secukinumab 300 mg - Reimbursement form prolongation (French)

      Download French document    
  • previous
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
 of  17
  • next

Filter by specialism:

Subscribe to Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2025 Novartis Belgium and Luxembourg
  • Terms of use
  • Privacy Policy
  • About cookies
This website is intended for health care professionals in Belgium and Luxembourg